Bank of Nova Scotia »

Cytomx Therapeutics shares owned by Bank of Nova Scotia

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by Bank of Nova Scotia from 13F filings

Historical chart of Bank of Nova Scotia investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by Bank of Nova Scotia consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by Bank of Nova Scotia

Quarter filed Position value Share count Share price at filing
2025-12-31 $58k 14k 4.26

More positions owned by Bank of Nova Scotia

NVIDIA Corporation (NVDA)
Key (KEY)
Microsoft Corporation (MSFT)
Rbc Cad (RY)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Toronto Dominion Bk Ont Com New (TD)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Cibc Cad (CM)
Micron Technology (MU)
Tesla Motors (TSLA)

View all positions for Bank of Nova Scotia

Top funds holding Cytomx Therapeutics

VR Adviser
FMR
Perceptive Advisors
Vanguard Group
OrbiMed Advisors
Commodore Capital
Point72 Asset Management
State Street Corporation
Balyasny Asset Management
ADAR1 Capital Management
Baker Bros. Advisors
Financial Engines Advisors L.L.C
Kynam Capital Management
Ikarian Capital
Vivo Capital

View all funds holding Cytomx Therapeutics